| male gamete generation | GO:0048232 | 285 | 0.190 | |
| positive regulation of transcription from rna polymerase i promoter | GO:0045943 | 3 | 0.120 | |
| rna processing | GO:0006396 | 105 | 0.116 | |
| gonad development | GO:0008406 | 141 | 0.101 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.091 | |
| translation | GO:0006412 | 93 | 0.078 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.066 | |
| germ cell development | GO:0007281 | 185 | 0.064 | |
| lung development | GO:0030324 | 164 | 0.063 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.057 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.057 | |
| body morphogenesis | GO:0010171 | 45 | 0.056 | |
| camera type eye development | GO:0043010 | 266 | 0.056 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.056 | |
| mesoderm development | GO:0007498 | 100 | 0.056 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.055 | |
| genitalia development | GO:0048806 | 37 | 0.055 | |
| regulation of translation | GO:0006417 | 71 | 0.054 | |
| spermatogenesis | GO:0007283 | 284 | 0.053 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.053 | |
| male gonad development | GO:0008584 | 88 | 0.053 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.051 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.047 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.046 | |
| spermatid differentiation | GO:0048515 | 115 | 0.043 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.042 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.042 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.041 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.039 | |
| regulation of cell activation | GO:0050865 | 289 | 0.039 | |
| stem cell differentiation | GO:0048863 | 268 | 0.038 | Zebrafish |
| regionalization | GO:0003002 | 337 | 0.037 | |
| respiratory tube development | GO:0030323 | 167 | 0.037 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.037 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.036 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.035 | |
| protein sumoylation | GO:0016925 | 14 | 0.035 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.034 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.034 | |
| rna interference | GO:0016246 | 2 | 0.034 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.033 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.033 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.032 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.032 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.032 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.032 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.032 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.031 | |
| regulation of binding | GO:0051098 | 111 | 0.031 | |
| ribosomal small subunit biogenesis | GO:0042274 | 4 | 0.031 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.030 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.029 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.029 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.029 | |
| fertilization | GO:0009566 | 127 | 0.029 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.028 | |
| membrane organization | GO:0061024 | 245 | 0.028 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.028 | |
| segmentation | GO:0035282 | 93 | 0.027 | |
| respiratory system development | GO:0060541 | 190 | 0.027 | |
| regulation of cell motility | GO:2000145 | 236 | 0.026 | |
| protein maturation | GO:0051604 | 176 | 0.026 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.026 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.026 | |
| spermatid development | GO:0007286 | 108 | 0.026 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.026 | |
| endomembrane system organization | GO:0010256 | 147 | 0.025 | |
| digestive system development | GO:0055123 | 200 | 0.025 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.025 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.024 | |
| forebrain development | GO:0030900 | 302 | 0.024 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.024 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.024 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.024 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.023 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.023 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.023 | |
| cellular response to sterol depletion | GO:0071501 | 4 | 0.023 | |
| palate development | GO:0060021 | 76 | 0.023 | |
| inflammatory response | GO:0006954 | 244 | 0.023 | |
| male sex differentiation | GO:0046661 | 109 | 0.022 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.022 | |
| ossification | GO:0001503 | 216 | 0.022 | |
| oogenesis | GO:0048477 | 56 | 0.022 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.022 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.021 | |
| translational initiation | GO:0006413 | 24 | 0.021 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.021 | |
| blood circulation | GO:0008015 | 195 | 0.021 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.021 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.021 | |
| circulatory system process | GO:0003013 | 197 | 0.021 | |
| endocytosis | GO:0006897 | 168 | 0.021 | |
| transmembrane transport | GO:0055085 | 412 | 0.021 | |
| ribosome biogenesis | GO:0042254 | 20 | 0.021 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.020 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.020 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.020 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.020 | |
| heart morphogenesis | GO:0003007 | 178 | 0.020 | |
| cell adhesion | GO:0007155 | 329 | 0.020 | |
| regulation of cell migration | GO:0030334 | 219 | 0.020 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.020 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.019 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.019 | |
| regulation of protein stability | GO:0031647 | 52 | 0.019 | |
| regulation of system process | GO:0044057 | 200 | 0.019 | |
| heart contraction | GO:0060047 | 93 | 0.019 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.018 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.018 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.018 | |
| pole plasm assembly | GO:0007315 | 2 | 0.018 | |
| negative regulation of binding | GO:0051100 | 39 | 0.018 | |
| protein folding | GO:0006457 | 28 | 0.018 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.018 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.018 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.018 | |
| protein methylation | GO:0006479 | 81 | 0.018 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.018 | |
| multicellular organism growth | GO:0035264 | 161 | 0.018 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.018 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.018 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.018 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.018 | |
| amine metabolic process | GO:0009308 | 45 | 0.017 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.017 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.017 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.017 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.017 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.017 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.017 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.017 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.017 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.016 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.016 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.016 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.016 | |
| female gamete generation | GO:0007292 | 74 | 0.016 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.016 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.016 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.016 | |
| t cell activation | GO:0042110 | 289 | 0.016 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.016 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.016 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.016 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.015 | |
| oocyte construction | GO:0007308 | 2 | 0.015 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.015 | |
| regulation of cell size | GO:0008361 | 72 | 0.015 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.015 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.015 | |
| protein refolding | GO:0042026 | 1 | 0.015 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.015 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.015 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.014 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.014 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.014 | |
| cellular response to lipid | GO:0071396 | 145 | 0.014 | |
| chromatin modification | GO:0016568 | 187 | 0.014 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.014 | |
| digestive tract development | GO:0048565 | 190 | 0.014 | |
| response to growth factor | GO:0070848 | 198 | 0.014 | |
| single fertilization | GO:0007338 | 82 | 0.014 | |
| tissue homeostasis | GO:0001894 | 115 | 0.014 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.013 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.013 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.013 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.013 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.013 | |
| manganese ion transport | GO:0006828 | 5 | 0.013 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.013 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.013 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.013 | |
| angiogenesis | GO:0001525 | 201 | 0.013 | |
| atp metabolic process | GO:0046034 | 75 | 0.013 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.013 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.013 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.013 | |
| calcium ion transport | GO:0006816 | 159 | 0.013 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.012 | |
| oocyte development | GO:0048599 | 33 | 0.012 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.012 | |
| mesenchyme development | GO:0060485 | 152 | 0.012 | Zebrafish |
| nitrogen compound transport | GO:0071705 | 271 | 0.012 | |
| nuclear transport | GO:0051169 | 139 | 0.012 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.012 | |
| organelle localization | GO:0051640 | 179 | 0.012 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.012 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.012 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.012 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.012 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.012 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.012 | |
| ncrna processing | GO:0034470 | 26 | 0.012 | |
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902042 | 11 | 0.012 | |
| wound healing | GO:0042060 | 157 | 0.012 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.012 | |
| protein alkylation | GO:0008213 | 81 | 0.012 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.012 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.012 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.012 | |
| protein catabolic process | GO:0030163 | 221 | 0.011 | |
| regulation of transcription from rna polymerase i promoter | GO:0006356 | 6 | 0.011 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.011 | |
| axonogenesis | GO:0007409 | 274 | 0.011 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.011 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.011 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.011 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.011 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.011 | |
| rna splicing | GO:0008380 | 54 | 0.011 | |
| protein ubiquitination | GO:0016567 | 171 | 0.011 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.011 | |
| gastrulation | GO:0007369 | 116 | 0.011 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.011 | |
| protein localization to organelle | GO:0033365 | 185 | 0.011 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.011 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.011 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.011 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.011 | |
| cation transport | GO:0006812 | 399 | 0.011 | |
| lipid localization | GO:0010876 | 126 | 0.011 | |
| cell growth | GO:0016049 | 130 | 0.011 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.011 | |
| negative regulation of translation | GO:0017148 | 22 | 0.010 | |
| mrna metabolic process | GO:0016071 | 84 | 0.010 | |
| organelle fission | GO:0048285 | 170 | 0.010 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.010 | |
| positive regulation of the force of heart contraction by chemical signal | GO:0003099 | 3 | 0.010 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.010 | |
